These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18726842)

  • 1. Assessment of a biliary hamartoma with contrast-enhanced sonography using two different contrast agents.
    Hohmann J; Loddenkemper C; Albrecht T
    Ultraschall Med; 2009 Apr; 30(2):185-8. PubMed ID: 18726842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging diagnosis-cholangiocellular adenoma: contrast-enhanced ultrasonographic findings of a benign tumor mimicking malignant neoplasia in a dog.
    Baron Toaldo M; Diana A; Bettini G; Di Donato P; Linta N; Cipone M
    Vet Radiol Ultrasound; 2013; 54(1):71-4. PubMed ID: 23094700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma.
    Ignee A; Piscaglia F; Ott M; Salvatore V; Dietrich CF
    Scand J Gastroenterol; 2009; 44(5):633-6. PubMed ID: 19396663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound.
    Liu LN; Xu HX; Zheng SG; Sun LP; Guo LH; Zhang YF; Xu JM; Liu C; Xu XH
    Ultraschall Med; 2015 Dec; 36(6):594-602. PubMed ID: 25188491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry.
    Heide R; Strobel D; Bernatik T; Goertz RS
    Ultraschall Med; 2010 Aug; 31(4):405-9. PubMed ID: 20652853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
    Wang ZL; Tang J; Weskott HP; Li JL; Wang W; Luo YK; An LC; Xu JH
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1511-9. PubMed ID: 18713302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
    Bohle W; Clemens PU; Heubach T; Zoller WG
    Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
    von Herbay A; Westendorff J; Gregor M
    J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic findings in multiple bile-duct hamartomas of the liver.
    McLoughlin MJ; Phillips MJ
    Radiology; 1975 Jul; 116(1):41-3. PubMed ID: 1138280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma.
    Li C; Wang W; Ding H; Huang B; Cao J; Mao F; Ji Z
    J Clin Ultrasound; 2011 Oct; 39(8):447-53. PubMed ID: 21626512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
    Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
    Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The radiologic and pathologic spectrum of biliary hamartomas.
    Lev-Toaff AS; Bach AM; Wechsler RJ; Hilpert PL; Gatalica Z; Rubin R
    AJR Am J Roentgenol; 1995 Aug; 165(2):309-13. PubMed ID: 7618546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver tumor characterization--review of the literature.
    Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple bile duct hamartomas of the liver -- a rare differential diagnosis to liver metastasis].
    Hettinger M; Klotz M; Bolay L; Weber P
    Ultraschall Med; 2005 Apr; 26(2):150-3. PubMed ID: 15852180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A)--comparison of SonoVue and Levovist in HCC.
    von Herbay A; Haeussinger D; Gregor M; Vogt C
    Ultraschall Med; 2007 Apr; 28(2):168-75. PubMed ID: 17447216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.